Diabetes remission and relapse after metabolic surgery

Area of Science:

• Endocrinology
• Bariatric Surgery
• Metabolic Disorders

Background:

• Metabolic surgery offers a viable treatment for obesity and type 2 diabetes mellitus (T2DM).
• Long-term follow-up reveals declining remission rates and increased relapse frequency after 10-15 years post-surgery.
• Obesity and T2DM management requires understanding long-term outcomes.

Discussion:

• Investigating predictors of sustained T2DM remission versus relapse is crucial.
• Gastrointestinal hormones and metabolic profiles are potential key factors influencing long-term surgical outcomes.
• Understanding these predictors can guide personalized treatment strategies.

Key Insights:

• Metabolic surgery's long-term efficacy for T2DM in obese individuals is challenged by late relapses.
• Gastrointestinal hormone levels and metabolic markers may predict the durability of T2DM remission.
• Further research is needed to identify specific biomarkers for predicting T2DM relapse after surgery.

Outlook:

• Future studies should focus on identifying specific gastrointestinal hormone and metabolic predictors.
• This research aims to improve patient selection and long-term management strategies for T2DM post-metabolic surgery.
• Enhancing long-term T2DM remission rates in obese patients is a critical clinical goal.